{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:46:07Z","timestamp":1794843967888,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of Chin","doi-asserted-by":"crossref","award":["81970283"],"award-info":[{"award-number":["81970283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81900336"],"award-info":[{"award-number":["81900336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U1605226"],"award-info":[{"award-number":["U1605226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010166","name":"Xiamen Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["3502Z20184025"],"award-info":[{"award-number":["3502Z20184025"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010166","name":"Xiamen Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["3502Z20184024"],"award-info":[{"award-number":["3502Z20184024"]}],"id":[{"id":"10.13039\/100010166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies have demonstrated that human cardiac c-Kit<jats:sup>+<\/jats:sup> progenitor cells (hCPCs) can effectively improve ischemic heart disease. However, the major challenge in applying hCPCs to clinical therapy is the low survival rate of graft hCPCs in the host heart, which limited the benefit of transplanted hCPCs. Bradykinin (BK) is a principal active agent of the tissue kinin-kallikrein system. Our previous studies have highlighted that BK mediated the growth and migration of CPCs by regulating Ca<jats:sup>2+<\/jats:sup> influx. However, the protective effect of BK on CPCs, improvement in the survival rate of BK-pretreated hCPCs in the infarcted heart, and the related mechanism remain elusive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>HCPCs were treated with H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> to induce cell apoptosis and autophagy, and different concentration of BK was applied to rescue the H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>-induced injury detected by MTT assay, TUNEL staining, flow cytometry, western blotting, and mitoSOX assays. The role of autophagy in the anti-apoptotic effect of BK was chemically activated or inhibited using the autophagy inducer, rapamycin, or the inhibitor, 3-methyladenine (3-MA). To explore the protective effect of BK on hCPCs, 3-MA or BK-pretreated hCPCs were transplanted into the myocardial infarcted rats. An echocardiogram was used to determine cardiac function, H&amp;E and Masson staining were employed to assess pathological characteristics, HLA gene expression was quantified by qRT-PCR, and immunostaining was applied to examine neovascularization using confocal microscopy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The in vitro results showed that BK suppressed H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>-induced hCPCs apoptosis and ROS production in a concentration-dependent manner by promoting pAkt and Bcl-2 expression and reducing cleaved caspase 3 and Bax expression. Moreover, BK restrained the H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>-induced cell autophagy by decreasing LC3II\/I, Beclin1, and ATG5 expression and increasing P62 expression. In the in vivo experiment, the transplanted BK- or 3-MA-treated hCPCs were found to be\u00a0more effectively improved cardiac function by decreasing cardiomyocyte apoptosis, inflammatory infiltration, and myocardial fibrosis, and promoting neovascularization in the infarcted heart, compared to untreated-hCPCs or c-kit<jats:sup>-<\/jats:sup> cardiomyocytes (CPC<jats:sup>-<\/jats:sup> cells).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our present study established a new method to rescue transplanted hCPCs in the infarcted cardiac area via regulating cell apoptosis and autophagy of hCPCs by pretreatment with BK, providing a new therapeutic option for heart failure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-021-02503-6","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T10:03:08Z","timestamp":1628157788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pretreatment of cardiac progenitor cells with bradykinin attenuates H2O2-induced cell apoptosis and improves cardiac function in rats by regulating autophagy"],"prefix":"10.1186","volume":"12","author":[{"given":"Chan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Zhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-2112","authenticated-orcid":false,"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"issue":"7","key":"2503_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/clc.20922","volume":"34","author":"MF Minicucci","year":"2011","unstructured":"Minicucci MF, Azevedo PS, Polegato BF, Paiva SA, Zornoff LA. Heart failure after myocardial infarction: clinical implications and treatment. Clin Cardiol. 2011;34(7):410\u20134. https:\/\/doi.org\/10.1002\/clc.20922.","journal-title":"Clin Cardiol"},{"key":"2503_CR2","doi-asserted-by":"publisher","unstructured":"Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113(6):810\u201334. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300219.","DOI":"10.1161\/CIRCRESAHA.113.300219"},{"key":"2503_CR3","doi-asserted-by":"publisher","unstructured":"Bolli R, Tang XL, Guo Y, Li Q. After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease.\u00a0Can J Physiol Pharmacol. 2021;99(2):129\u201339. https:\/\/doi.org\/10.1139\/cjpp-2020-0406.","DOI":"10.1139\/cjpp-2020-0406"},{"issue":"6983","key":"2503_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nature02460","volume":"428","author":"LB Balsam","year":"2004","unstructured":"Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428(6983):668\u201373. https:\/\/doi.org\/10.1038\/nature02460.","journal-title":"Nature"},{"issue":"7","key":"2503_CR5","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.117.029343","volume":"136","author":"T Eschenhagen","year":"2017","unstructured":"Eschenhagen T, Bolli R, Braun T, Field LJ, Fleischmann BK, Frisen J, et al. Cardiomyocyte regeneration: a consensus statement. Circulation. 2017;136(7):680\u20136. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029343.","journal-title":"Circulation"},{"issue":"6983","key":"2503_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nature02446","volume":"428","author":"CE Murry","year":"2004","unstructured":"Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428(6983):664\u20138. https:\/\/doi.org\/10.1038\/nature02446.","journal-title":"Nature"},{"issue":"7","key":"2503_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.115.307647","volume":"118","author":"XL Tang","year":"2016","unstructured":"Tang XL, Li Q, Rokosh G, Sanganalmath SK, Chen N, Ou Q, et al. Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res. 2016;118(7):1091\u2013105. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307647.","journal-title":"Circ Res"},{"key":"2503_CR8","doi-asserted-by":"publisher","first-page":"3536854","DOI":"10.1155\/2018\/3536854","volume":"2018","author":"K Dergilev","year":"2018","unstructured":"Dergilev K, Tsokolaeva Z, Makarevich P, Beloglazova I, Zubkova E, Boldyreva M, et al. C-kit cardiac progenitor cell based cell sheet improves vascularization and attenuates cardiac remodeling following myocardial infarction in rats. Biomed Res Int. 2018;2018:3536854.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2503_CR9","doi-asserted-by":"publisher","first-page":"H202","DOI":"10.1152\/ajpheart.01287.2004","volume":"289","author":"E Kintsurashvili","year":"2005","unstructured":"Kintsurashvili E, Duka A, Ignjacev I, Pattakos G, Gavras I, Gavras H. Age-related changes of bradykinin B1 and B2 receptors in rat heart. Am J Physiol Heart Circ Physiol. 2005;289(1):H202\u20135. https:\/\/doi.org\/10.1152\/ajpheart.01287.2004.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"2503_CR10","doi-asserted-by":"publisher","first-page":"17731","DOI":"10.1002\/jcb.29039","volume":"120","author":"C Fu","year":"2019","unstructured":"Fu C, Cao Y, Li B, Xu R, Sun Y, Yao Y. Bradykinin protects cardiac c-kit positive cells from high-glucose-induced senescence through B2 receptor signaling pathway. J Cell Biochem. 2019;120(10):17731\u201343. https:\/\/doi.org\/10.1002\/jcb.29039.","journal-title":"J Cell Biochem"},{"issue":"7","key":"2503_CR11","doi-asserted-by":"publisher","first-page":"10822","DOI":"10.18632\/oncotarget.14609","volume":"8","author":"G Li","year":"2017","unstructured":"Li G, Wang Y, Li GR. Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells. Oncotarget. 2017;8(7):10822\u201335. https:\/\/doi.org\/10.18632\/oncotarget.14609.","journal-title":"Oncotarget"},{"issue":"10","key":"2503_CR12","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1111\/jcmm.13706","volume":"22","author":"G Li","year":"2018","unstructured":"Li G, Che H, Wu WY, Jie LJ, Xiao GS, Wang Y, et al. Bradykinin-mediated Ca(2+) signalling regulates cell growth and mobility in human cardiac c-Kit(+) progenitor cells. J Cell Mol Med. 2018;22(10):4688\u201399. https:\/\/doi.org\/10.1111\/jcmm.13706.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"2503_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00395-014-0407-z","volume":"109","author":"YY Zhang","year":"2014","unstructured":"Zhang YY, Li G, Che H, Sun HY, Li X, Au WK, et al. Characterization of functional ion channels in human cardiac c-kit+ progenitor cells. Basic Res Cardiol. 2014;109(3):407. https:\/\/doi.org\/10.1007\/s00395-014-0407-z.","journal-title":"Basic Res Cardiol"},{"issue":"6","key":"2503_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","volume":"114","author":"AP Beltrami","year":"2003","unstructured":"Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114(6):763\u201376. https:\/\/doi.org\/10.1016\/S0092-8674(03)00687-1.","journal-title":"Cell"},{"issue":"10","key":"2503_CR15","doi-asserted-by":"publisher","first-page":"H1772","DOI":"10.1152\/ajpheart.00260.2015","volume":"309","author":"H Che","year":"2015","unstructured":"Che H, Li G, Sun HY, Xiao GS, Wang Y, Li GR. Roles of store-operated Ca2+ channels in regulating cell cycling and migration of human cardiac c-kit+ progenitor cells. Am J Physiol Heart Circ Physiol. 2015;309(10):H1772\u201381. https:\/\/doi.org\/10.1152\/ajpheart.00260.2015.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"2503_CR16","doi-asserted-by":"publisher","first-page":"e0138581","DOI":"10.1371\/journal.pone.0138581","volume":"10","author":"YY Zhang","year":"2015","unstructured":"Zhang YY, Li G, Che H, Sun HY, Xiao GS, Wang Y, et al. Effects of BKCa and Kir2.1 channels on cell cycling progression and migration in human cardiac c-kit+ progenitor cells. PLoS One. 2015;10(9):e0138581.","journal-title":"PLoS One"},{"issue":"6","key":"2503_CR17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/jcmm.12800","volume":"20","author":"H Che","year":"2016","unstructured":"Che H, Xiao GS, Sun HY, Wang Y, Li GR. Functional TRPV2 and TRPV4 channels in human cardiac c-kit(+) progenitor cells. J Cell Mol Med. 2016;20(6):1118\u201327. https:\/\/doi.org\/10.1111\/jcmm.12800.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"2503_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5966\/sctm.2015-0101","volume":"5","author":"S Golpanian","year":"2016","unstructured":"Golpanian S, Schulman IH, Ebert RF, Heldman AW, DiFede DL, Yang PC, et al. Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease. Stem Cells Transl Med. 2016;5(2):186\u201391. https:\/\/doi.org\/10.5966\/sctm.2015-0101.","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"2503_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2217\/fca-2018-0049","volume":"16","author":"E Fathi","year":"2020","unstructured":"Fathi E, Valipour B, Vietor I, Farahzadi R. An overview of the myocardial regeneration potential of cardiac c-Kit(+) progenitor cells via PI3K and MAPK signaling pathways. Future Cardiol. 2020;16(3):199\u2013209. https:\/\/doi.org\/10.2217\/fca-2018-0049.","journal-title":"Future Cardiol"},{"issue":"1","key":"2503_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/CIRCRESAHA.118.313215","volume":"123","author":"B Zhou","year":"2018","unstructured":"Zhou B, Wu SM. Reassessment of c-Kit in cardiac cells: a complex interplay between expression, fate, and function. Circ Res. 2018;123(1):9\u201311. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313215.","journal-title":"Circ Res"},{"issue":"12","key":"2503_CR21","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1002\/stem.2198","volume":"33","author":"C Cai","year":"2015","unstructured":"Cai C, Guo Y, Teng L, Nong Y, Tan M, Book MJ, et al. Preconditioning human cardiac stem cells with an HO-1 inducer exerts beneficial effects after cell transplantation in the infarcted murine heart. Stem Cells. 2015;33(12):3596\u2013607. https:\/\/doi.org\/10.1002\/stem.2198.","journal-title":"Stem Cells"},{"issue":"6","key":"2503_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1089\/cell.2011.0038","volume":"13","author":"KM Ng","year":"2011","unstructured":"Ng KM, Chan YC, Lee YK, Lai WH, Au KW, Fung ML, et al. Cobalt chloride pretreatment promotes cardiac differentiation of human embryonic stem cells under atmospheric oxygen level. Cell Reprogram. 2011;13(6):527\u201337. https:\/\/doi.org\/10.1089\/cell.2011.0038.","journal-title":"Cell Reprogram"},{"issue":"2","key":"2503_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/stem.574","volume":"29","author":"D Shinmura","year":"2011","unstructured":"Shinmura D, Togashi I, Miyoshi S, Nishiyama N, Hida N, Tsuji H, et al. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function. Stem Cells. 2011;29(2):357\u201366. https:\/\/doi.org\/10.1002\/stem.574.","journal-title":"Stem Cells"},{"issue":"5","key":"2503_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/SHK.0000000000000998","volume":"49","author":"H Qi","year":"2018","unstructured":"Qi H, Soto-Gonzalez L, Krychtiuk KA, Ruhittel S, Kaun C, Speidl WS, et al. Pretreatment with argon protects human cardiac myocyte-like progenitor cells from oxygen glucose deprivation-induced cell death by activation of AKT and differential regulation of mapkinases. Shock. 2018;49(5):556\u201363. https:\/\/doi.org\/10.1097\/SHK.0000000000000998.","journal-title":"Shock"},{"issue":"7-8","key":"2503_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41434-019-0084-5","volume":"26","author":"K Broughton","year":"2019","unstructured":"Broughton K, Korski K, Echeagaray O, Adamson R, Dembitsky W, Lu Z, et al. Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells. Gene Ther. 2019;26(7-8):324\u201337. https:\/\/doi.org\/10.1038\/s41434-019-0084-5.","journal-title":"Gene Ther"},{"key":"2503_CR26","doi-asserted-by":"publisher","unstructured":"Zhang Z, Yang J, Yan W, Li Y, Shen Z, Asahara T. Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. J Am Heart Assoc. 2016;5:e002856. https:\/\/doi.org\/10.1161\/JAHA.115.002856.","DOI":"10.1161\/JAHA.115.002856"},{"issue":"1","key":"2503_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1124\/pr.57.1.2","volume":"57","author":"LM Leeb-Lundberg","year":"2005","unstructured":"Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005;57(1):27\u201377. https:\/\/doi.org\/10.1124\/pr.57.1.2.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"2503_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1515\/bc.2010.042","volume":"391","author":"J Chao","year":"2010","unstructured":"Chao J, Shen B, Gao L, Xia CF, Bledsoe G, Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biol Chem. 2010;391(4):345\u201355.","journal-title":"Biol Chem"},{"issue":"4","key":"2503_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.108.114587","volume":"52","author":"J Chao","year":"2008","unstructured":"Chao J, Yin H, Gao L, Hagiwara M, Shen B, Yang ZR, et al. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Hypertension. 2008;52(4):715\u201320. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.114587.","journal-title":"Hypertension"},{"issue":"8","key":"2503_CR30","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/CIRCRESAHA.115.307676","volume":"118","author":"PP Zwetsloot","year":"2016","unstructured":"Zwetsloot PP, Vegh AM. Jansen of Lorkeers SJ, van Hout GP, Currie GL, Sena ES, Gremmels H, Buikema JW, Goumans MJ, Macleod MR et al: Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ Res. 2016;118(8):1223\u201332. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307676.","journal-title":"Circ Res"},{"issue":"7","key":"2503_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1139\/y03-065","volume":"81","author":"MJ Dumoulin","year":"2003","unstructured":"Dumoulin MJ, Adam A, Rouleau JL, Gosselin H, Lamontagne D. Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction. Can J Physiol Pharmacol. 2003;81(7):740\u20136. https:\/\/doi.org\/10.1139\/y03-065.","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"2503_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.bjp.0705013","volume":"138","author":"H Ito","year":"2003","unstructured":"Ito H, Hayashi I, Izumi T, Majima M. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Br J Pharmacol. 2003;138(1):225\u201333. https:\/\/doi.org\/10.1038\/sj.bjp.0705013.","journal-title":"Br J Pharmacol"},{"issue":"28","key":"2503_CR33","doi-asserted-by":"publisher","first-page":"24675","DOI":"10.18632\/oncotarget.5071","volume":"6","author":"C Fu","year":"2015","unstructured":"Fu C, Li B, Sun Y, Ma G, Yao Y. Bradykinin inhibits oxidative stress-induced senescence of endothelial progenitor cells through the B2R\/AKT\/RB and B2R\/EGFR\/RB signal pathways. Oncotarget. 2015;6(28):24675\u201389. https:\/\/doi.org\/10.18632\/oncotarget.5071.","journal-title":"Oncotarget"},{"issue":"18","key":"2503_CR34","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1242\/jcs.192534","volume":"129","author":"MM Pillat","year":"2016","unstructured":"Pillat MM, Lameu C, Trujillo CA, Glaser T, Cappellari AR, Negraes PD, et al. Bradykinin promotes neuron-generating division of neural progenitor cells through ERK activation. J Cell Sci. 2016;129(18):3437\u201348. https:\/\/doi.org\/10.1242\/jcs.192534.","journal-title":"J Cell Sci"},{"issue":"12","key":"2503_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081505","volume":"8","author":"Z Sheng","year":"2013","unstructured":"Sheng Z, Yao Y, Li Y, Yan F, Huang J, Ma G. Bradykinin preconditioning improves therapeutic potential of human endothelial progenitor cells in infarcted myocardium. PLoS One. 2013;8(12):e81505. https:\/\/doi.org\/10.1371\/journal.pone.0081505.","journal-title":"PLoS One"},{"issue":"6","key":"2503_CR36","first-page":"1045","volume":"7","author":"ZL Sheng","year":"2015","unstructured":"Sheng ZL, Yao YY, Li YF, Fu C, Ma GS. Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt\/eNOS phosphorylation and angiogenesis. Am J Transl Res. 2015;7(6):1045\u201357.","journal-title":"Am J Transl Res"},{"key":"2503_CR37","doi-asserted-by":"publisher","unstructured":"Park JH, Choi SH, Kim H, Ji ST, Jang WB, Kim JH, et al. Doxorubicin regulates autophagy signals via accumulation of cytosolic Ca(2+) in human cardiac progenitor cells. Int J Mol Sci. 2016;17(10):1680. https:\/\/doi.org\/10.3390\/ijms17101680.","DOI":"10.3390\/ijms17101680"},{"issue":"1","key":"2503_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13287-017-0543-0","volume":"8","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Yang C, Shen M, Yang M, Jin Z, Ding L, et al. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction. Stem Cell Res Ther. 2017;8(1):89. https:\/\/doi.org\/10.1186\/s13287-017-0543-0.","journal-title":"Stem Cell Res Ther"},{"key":"2503_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2018.05.021","volume":"32","author":"W Ma","year":"2018","unstructured":"Ma W, Ding F, Wang X, Huang Q, Zhang L, Bi C, et al. By targeting Atg7 MicroRNA-143 mediates oxidative stress-induced autophagy of c-Kit(+) mouse cardiac progenitor cells. EBioMedicine. 2018;32:182\u201391. https:\/\/doi.org\/10.1016\/j.ebiom.2018.05.021.","journal-title":"EBioMedicine"},{"issue":"44","key":"2503_CR40","doi-asserted-by":"publisher","first-page":"77634","DOI":"10.18632\/oncotarget.20747","volume":"8","author":"X Shi","year":"2017","unstructured":"Shi X, Li W, Liu H, Yin D, Zhao J. The ROS\/NF-kappaB\/NR4A2 pathway is involved in H2O2 induced apoptosis of resident cardiac stem cells via autophagy. Oncotarget. 2017;8(44):77634\u201348. https:\/\/doi.org\/10.18632\/oncotarget.20747.","journal-title":"Oncotarget"},{"issue":"22","key":"2503_CR41","first-page":"4076","volume":"125","author":"FR Lei","year":"2012","unstructured":"Lei FR, Li XQ, Liu H, Zhu RD, Meng QY, Rong JJ. Rapamycin and 3-methyladenine regulate apoptosis and autophagy in bone-derived endothelial progenitor cells. Chin Med J (Engl). 2012;125(22):4076\u201382.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"2503_CR42","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/jcmm.13434","volume":"22","author":"C Wang","year":"2018","unstructured":"Wang C, Mao C, Lou Y, Xu J, Wang Q, Zhang Z, et al. Monotropein promotes angiogenesis and inhibits oxidative stress-induced autophagy in endothelial progenitor cells to accelerate wound healing. J Cell Mol Med. 2018;22(3):1583\u2013600. https:\/\/doi.org\/10.1111\/jcmm.13434.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"2503_CR43","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3892\/ijmm.2018.3794","volume":"42","author":"X Li","year":"2018","unstructured":"Li X, Hu X, Wang J, Xu W, Yi C, Ma R, et al. Inhibition of autophagy via activation of PI3K\/Akt\/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia\/reperfusion injury. Int J Mol Med. 2018;42(4):1917\u201324. https:\/\/doi.org\/10.3892\/ijmm.2018.3794.","journal-title":"Int J Mol Med"},{"issue":"14","key":"2503_CR44","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.4103\/0366-6999.235867","volume":"131","author":"YY Liu","year":"2018","unstructured":"Liu YY, Sun C, Xue FS, Yang GZ, Li HX, Liu Q, et al. Effect of autophagy inhibition on the protection of ischemia preconditioning against myocardial ischemia\/reperfusion injury in diabetic rats. Chin Med J (Engl). 2018;131(14):1702\u20139. https:\/\/doi.org\/10.4103\/0366-6999.235867.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"2503_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12860-020-00286-x","volume":"21","author":"YM Jeong","year":"2020","unstructured":"Jeong YM, Cheng XW, Lee KH, Lee S, Cho H, Kim W. Substance P enhances the local activation of NK1R-expressing c-kit(+) cardiac progenitor cells in right atrium of ischemia\/reperfusion-injured heart. BMC Mol Cell Biol. 2020;21(1):41. https:\/\/doi.org\/10.1186\/s12860-020-00286-x.","journal-title":"BMC Mol Cell Biol"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02503-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02503-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02503-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T10:11:09Z","timestamp":1628158269000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02503-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2503"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02503-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"assertion":[{"value":"29 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of Xiamen Cardiovascular Hospital, Xiamen University. Informed consent was obtained from all participants included in the study. All animal experiments were performed according to the guidelines of the Institutional Animal Care and Use Committee of Xiamen University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}